Within tumors themselves, Vδ1 T cells display a tissue-resident CD103+ phenotype, potentially improving their tumor-homing and tumor-retention capabilities vis-à-vis adoptive cell therapy. The gene discussed is ITGAE; the disease is neoplasm.